ArticleFrontiers in pediatrics2025
Endobronchial blocker and extracorporeal membrane oxygenation use for lung abscess complicated by a bronchopleural fistula in a pediatric patient: a case report and literature review.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: A lung abscess is a thick-walled cavity containing purulent material that results from pulmonary infection. It is an uncommon condition that can occur at any age. Bronchopleural fistula (BPF) is a severe complication with a poor prognosis that may arise with the progression of the condition or as a result of treatment. Case presentation: We describe a case of lung abscess complicated by a BPF and septic shock in a 7-year-old girl. A chest tube was inserted and venoarterial extracorporeal membrane oxygenation (ECMO) was emergently used. To selectively block the BPF, an endobronchial blocker was placed in the right intermediate bronchus under bronchoscopic guidance. This approach allowed the BPF to heal, enabled the recruitment of the other lung, and obstructed the purulent fluid. The patient recovered and was discharged after 70 days of treatment. Conclusions: This case demonstrates that combined endobronchial blocker and ECMO can be an effective approach for patients with lung abscesses and BPFs (especially those aged < 8 years) when the adjustment of conventional therapy is unsuccessful.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.